Medicare Enrolled
Dr. Khalil Katato, M.D.
Hematology & Oncology · Flint, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Katato from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katato?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Katato
Dr. Khalil Katato is a hematology & oncology specialist in Flint, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Katato performed 36,297 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Katato received a total of $4,938 from 60 pharmaceutical and/or device companies across 207 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Katato is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in MI
$4,938 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗36,297
Medicare services
Top 13% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
29,580 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 3,360 | $18 | $30 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
733 | $8 | $21 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
595 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 480 | $1 | $120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
269 | $57 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
236 | $89 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
210 | $10 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
113 | $95 | $220 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
110 | $21 | $60 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
98 | $11 | $30 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
95 | $94 | $205 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $60 | $110 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
67 | $46 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $110 | $242 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
42 | $47 | $115 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
37 | $53 | $145 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
31 | $1 | $12 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
30 | $21 | $55 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
28 | $67 | $180 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
23 | $1 | $5 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
22 | $1 | $5 |
| New patient office visit, complex (60-74 min) | 11 | $155 | $310 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
82.4% high complexity
13.4% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,938
Total received (2018-2024)
Avg $705/year across 7 years
Top 30% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
207
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,106
2023
$1,351
2022
$907
2021
$430
2020
$46
2019
$20
2018
$77
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$662
Novartis Pharmaceuticals Corporation
$360
PFIZER INC.
$111
E.R. Squibb & Sons, L.L.C.
$98
Janssen Biotech, Inc.
$73
Incyte Corporation
$72
Genentech USA, Inc.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$65
Celgene Corporation
$58
Gilead Sciences, Inc.
$44
BeiGene USA, Inc.
$42
EMD Serono, Inc.
$37
Regeneron Healthcare Solutions, Inc.
$35
Lilly USA, LLC
$32
Dendreon Pharmaceuticals LLC
$32
JAZZ PHARMACEUTICALS INC.
$29
Janssen Pharmaceuticals, Inc
$26
GENZYME CORPORATION
$25
PharmaEssentia USA Corporation
$25
Acrotech Biopharma Inc.
$23
ABBVIE INC.
$22
Mirati Therapeutics, Inc.
$22
Kyowa Kirin, Inc.
$21
Deciphera Pharmaceuticals Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
GlaxoSmithKline, LLC.
$18
Ipsen Biopharmaceuticals, Inc
$18
Daiichi Sankyo Inc.
$17
Apellis Pharmaceuticals, Inc.
$17
Aveo Pharmaceuticals, Inc.
$13
Top 3 companies account for 53.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$748
Novartis Pharmaceuticals Corporation
$587
Genentech USA, Inc.
$253
Janssen Biotech, Inc.
$245
Celgene Corporation
$176
Pharmacosmos Therapeutics Inc.
$176
Pharmacyclics LLC, An AbbVie Company
$174
E.R. Squibb & Sons, L.L.C.
$171
PFIZER INC.
$170
GlaxoSmithKline, LLC.
$123
Amgen Inc.
$116
GENZYME CORPORATION
$105
Astellas Pharma US Inc
$100
JAZZ PHARMACEUTICALS INC.
$87
Kite Pharma, Inc.
$87
Incyte Corporation
$87
Dendreon Pharmaceuticals LLC
$78
Deciphera Pharmaceuticals Inc.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$65
BeiGene USA, Inc.
$64
Seagen Inc.
$63
Gilead Sciences, Inc.
$63
Regeneron Healthcare Solutions, Inc.
$57
AVEO Pharmaceuticals, Inc.
$57
Ipsen Biopharmaceuticals, Inc
$53
EMD Serono, Inc.
$52
Lilly USA, LLC
$49
Apellis Pharmaceuticals, Inc.
$47
Karyopharm Therapeutics Inc.
$45
Adaptive Biotechnologies Corporation
$45
Alexion Pharmaceuticals, Inc.
$40
Coherus Biosciences Inc.
$40
Daiichi Sankyo Inc.
$40
Acrotech Biopharma Inc.
$38
Emmaus Medical, Inc.
$36
AMAG Pharmaceuticals, Inc.
$34
Novo Nordisk Inc
$33
Exelixis Inc.
$31
Foundation Medicine, Inc.
$29
Janssen Pharmaceuticals, Inc
$26
PharmaEssentia USA Corporation
$25
Genmab U.S., Inc.
$24
TerSera Therapeutics LLC
$23
ABBVIE INC.
$22
Mirati Therapeutics, Inc.
$22
Eisai Inc.
$21
Kyowa Kirin, Inc.
$21
Philips Electronics North America Corporation
$20
Spectrum Pharmaceuticals Inc.
$19
Acrotech Biopharma LLC
$19
CSL Behring
$19
Rigel Pharmaceuticals, Inc.
$19
Sumitomo Pharma America, Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$18
Merck Sharp & Dohme LLC
$18
G1 Therapeutics, Inc.
$15
Stemline Therapeutics Inc.
$15
Aveo Pharmaceuticals, Inc.
$13
GE HealthCare
$12
Pharmacyclics LLC, an AbbVie Company
$12
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
Abraxane · Alecensa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · BrillCT BigBore Base · CABLIVI · CALQUENCE · COSELA · Cabometyx · Columvi · DARZALEX · ELAHERE · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · ICLUSIG · IMBRUVICA · Idelvion · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · Monoferric · Novoeight · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PROMACTA · PROVENGE · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Rebinyn · SARCLISA · SOMATULINE DEPOT · SYLVANT · TAGRISSO · TASIGNA · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · ULTOMIRIS · Udenyca · VERZENIO · Venclexta · XPOVIO · XTANDI · XYNTHA · Xermelo · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
16
County median income
$60,673
Nearest hospital to ZIP centroid (approximate)
HURLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Katato is a mixed practice specialist, with above-average Medicare volume (top 13% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Katato experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Katato performed 29,580 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Katato receive payments from pharmaceutical companies?
Yes. Dr. Katato received a total of $4,938 from 60 companies across 207 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katato's costs compare to other hematology & oncology specialists in Flint?
Dr. Katato's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katato) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Flint
Browse hematology & oncology specialists in Flint ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology